News & Events
News & Events
April 23, 2018
Critical Path to TB Drug Regimens (CPTR) 2018 Annual WorkshopWHAT: Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop WHEN: Monday, April 23 through Wednesday, April 25, 2018 For planning purposes, please note breakfast will begin at 7:15 a.m. each day and the program will adjourn by 5 p.m. Receptions will be hosted on Monday and Tuesday evenings. WHERE: Washington, DC W Hotel...
October 18, 2017
C-Path and CDISC Announce Therapeutic Area User Guide for Duchenne Muscular DystrophyOctober 18, 2017 TUCSON, Ariz., and AUSTIN, Texas – October 18, 2017 –Critical Path Institute (C-Path) and The Clinical Data Interchange Standards Consortium (CDISC) announce the open availability of a Duchenne Muscular Dystrophy Therapeutic Area User Guide (TAUG-DMD v1.0), which describes the most common clinical concepts relevant to Duchenne studies using the CDISC standard format. This format...
October 9, 2017
Critical Path Innovation MeetingOn September 14, 2017, Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium and Electronic Patient-Reported Outcome (ePRO) Consortium participated in a Critical Path Innovation Meeting (CPIM) at the U.S Food and Drug Administration’s (FDA) White Oak campus in Silver Spring, MD. As stated on FDA’s website, the goals for CPIMs are “to discuss a methodology...
September 11, 2017
C-Path, CHDI Foundation, and CDISC Announce Public Review Period for Huntington’s Disease Therapeutic Area User GuideSeptember 11, 2017 TUCSON, AZ, NEW YORK, NY, and AUSTIN, TX – September 11, 2017 – Critical Path Institute (C-Path), CHDI Foundation, Inc. (CHDI), and The Clinical Data Interchange Standards Consortium (CDISC) announce the availability of a draft Huntington’s disease (HD) Therapeutic Area User Guide (TAUG-HD v1.0) for public review. The TAUG-HD v1.0...
June 13, 2017
C-Path and CDISC Announce Public Review Period for Duchenne Therapeutic Area StandardJune 13, 2017 TUCSON, Ariz., and AUSTIN, Texas – June 13, 2017 – The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the availability of a Duchenne muscular dystrophy therapeutic area user guide (TAUG-DMD v1.0) for public review. The review period for the TAUG-DMD v1.0 began on May 8, 2017, and runs through July 6,...